Literature DB >> 19795979

Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates.

Chiara Ripamonti1, Abigail Orenstein, Geetha Kutty, Laurence Huang, Regina Schuhegger, Andreas Sing, Giovanna Fantoni, Chiara Atzori, Carol Vinton, Charles Huber, Patricia S Conville, Joseph A Kovacs.   

Abstract

Better understanding of the epidemiology and transmission patterns of human Pneumocystis should lead to improved strategies for preventing Pneumocystis pneumonia (PCP). We have developed a typing method for Pneumocystis jirovecii that is based on restriction fragment length polymorphism (RFLP) analysis after polymerase chain reaction amplification of an approximately 1300 base-pair region of the msg gene family, which comprises an estimated 50-100 genes/genome. The RFLP pattern was reproducible in samples containing >1000 msg copies/reaction and was stable over time, based on analysis of serial samples from the same patient. In our initial analysis of 48 samples, we found that samples obtained from different individuals showed distinct banding patterns; only samples obtained from the same patient showed an identical RFLP pattern. Despite this substantial diversity, samples tended to cluster on the basis of country of origin. In an evaluation of samples obtained from an outbreak of PCP in kidney transplant recipients in Germany, RFLP analysis demonstrated identical patterns in samples that were from 12 patients previously linked to this outbreak, as well as from 2 additional patients. Our results highlight the presence of a remarkable diversity in human Pneumocystis strains. RFLP may be very useful for studying clusters of PCP in immunosuppressed patients, to determine whether there is a common source of infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795979      PMCID: PMC2803681          DOI: 10.1086/644643

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Residence at the expression site is necessary and sufficient for the transcription of surface antigen genes of Pneumocystis carinii.

Authors:  S M Sunkin; J R Stringer
Journal:  Mol Microbiol       Date:  1997-07       Impact factor: 3.501

2.  New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V J Gill; S Meshnick; H Masur
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

3.  Characterization of the expression site of the major surface glycoprotein of human-derived Pneumocystis carinii.

Authors:  G Kutty; L Ma; J A Kovacs
Journal:  Mol Microbiol       Date:  2001-10       Impact factor: 3.501

4.  Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.

Authors:  C H Lee; J Helweg-Larsen; X Tang; S Jin; B Li; M S Bartlett; J J Lu; B Lundgren; J D Lundgren; M Olsson; S B Lucas; P Roux; A Cargnel; C Atzori; O Matos; J W Smith
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 5.  Typing methods to approach Pneumocystis carinii genetic heterogeneity.

Authors:  P M Hauser; D S Blanc; J Bille; P Francioli
Journal:  FEMS Immunol Med Microbiol       Date:  1998-09

6.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

7.  Variation in the major surface glycoprotein genes in Pneumocystis jirovecii.

Authors:  Geetha Kutty; Frank Maldarelli; Guillaume Achaz; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

8.  Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation.

Authors:  Sabine Schmoldt; Regina Schuhegger; Thorsten Wendler; Ingrid Huber; Heidelore Söllner; Michael Hogardt; Helmut Arbogast; Jürgen Heesemann; Lutz Bader; Andreas Sing
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

9.  Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

Authors:  Peter D Walzer; Hannah E R Evans; Andrew J Copas; Simon G Edwards; Alison D Grant; Robert F Miller
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

10.  Adaptation of HIV-1 to human leukocyte antigen class I.

Authors:  Yuka Kawashima; Katja Pfafferott; John Frater; Philippa Matthews; Rebecca Payne; Marylyn Addo; Hiroyuki Gatanaga; Mamoru Fujiwara; Atsuko Hachiya; Hirokazu Koizumi; Nozomi Kuse; Shinichi Oka; Anna Duda; Andrew Prendergast; Hayley Crawford; Alasdair Leslie; Zabrina Brumme; Chanson Brumme; Todd Allen; Christian Brander; Richard Kaslow; James Tang; Eric Hunter; Susan Allen; Joseph Mulenga; Songee Branch; Tim Roach; Mina John; Simon Mallal; Anthony Ogwu; Roger Shapiro; Julia G Prado; Sarah Fidler; Jonathan Weber; Oliver G Pybus; Paul Klenerman; Thumbi Ndung'u; Rodney Phillips; David Heckerman; P Richard Harrigan; Bruce D Walker; Masafumi Takiguchi; Philip Goulder
Journal:  Nature       Date:  2009-02-25       Impact factor: 49.962

View more
  16 in total

Review 1.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Characterization of the meiosis-specific recombinase Dmc1 of pneumocystis.

Authors:  Geetha Kutty; Guillaume Achaz; Frank Maldarelli; Ashok Varma; Robert Shroff; Steven Becker; Giovanna Fantoni; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

Review 3.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

Review 4.  Microbial antigenic variation mediated by homologous DNA recombination.

Authors:  Cornelis Vink; Gloria Rudenko; H Steven Seifert
Journal:  FEMS Microbiol Rev       Date:  2012-01-17       Impact factor: 16.408

5.  Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence.

Authors:  Monica Sassi; Chiara Ripamonti; Nicolas J Mueller; Hirohisa Yazaki; Geetha Kutty; Liang Ma; Charles Huber; Emile Gogineni; Shinichi Oka; Norihiko Goto; Thomas Fehr; Sara Gianella; Regina Konrad; Andreas Sing; Joseph A Kovacs
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

Review 6.  HIV-associated Pneumocystis pneumonia.

Authors:  Laurence Huang; Adithya Cattamanchi; J Lucian Davis; Saskia den Boon; Joseph Kovacs; Steven Meshnick; Robert F Miller; Peter D Walzer; William Worodria; Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2011-06

7.  Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii.

Authors:  Andreas A Rostved; Monica Sassi; Jørgen A L Kurtzhals; Søren Schwartz Sørensen; Allan Rasmussen; Christian Ross; Emile Gogineni; Charles Huber; Geetha Kutty; Joseph A Kovacs; Jannik Helweg-Larsen
Journal:  Transplantation       Date:  2013-11-15       Impact factor: 4.939

8.  Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii.

Authors:  S F Queener; V Cody; J Pace; P Torkelson; A Gangjee
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

9.  Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.

Authors:  Jayme L Dahlin; Theodore Kottom; Junhong Han; Hui Zhou; Michael A Walters; Zhiguo Zhang; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

Review 10.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.